Glenmark Pharmaceuticals informs about Press Release

21 May 2015 Evaluate

Glenmark Pharmaceuticals has informed about Press Release dated May 21, 2015, titled ‘Glenmark Pharmaceuticals receives tentative ANDA approval for Rufinamide Tablets USP’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1958.50 5.60 (0.29%)
11-Dec-2025 12:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.25
Dr. Reddys Lab 1274.00
Cipla 1508.40
Zydus Lifesciences 925.30
Lupin 2078.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×